Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 8, 2011, Pages 546-552

  Shaffer, J R ^a   Kammerer, C M ^a   Dorn, J ^b   Ferrell, R E ^a   Iacoviello, L ^c   Trevisan, M ^b,d   Donahue, R P ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d Nevada System of Higher Education   (United States)

Author keywords

Acute myocardial infarction; Glycoprotein 6; Hormone replacement therapy

Indexed keywords

FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENETIC MARKER; GENETICS; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; POSTMENOPAUSE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; MYOCARDIAL INFARCTION; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK FACTORS; THROMBOSIS;

EID: 79961128644     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.12.002     Document Type: Article

References (19)

1. Penz S., Reininger A.J., Brandl R., Goyal P., Rabie T., Bernlochner I., et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005 Jun, 19(8):898-909.
2. Best D., Senis Y.A., Jarvis G.E., Eagleton H.J., Roberts D.J., Saito T., et al. GPVI levels in platelets: relationship to platelet function at high shear. Blood 2003 Oct 15, 102(8):2811-2818.
3. Massberg S., Gawaz M., Gruner S., Schulte V., Konrad I., Zohlnhofer D., et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003 Jan 6, 197(1):41-49.
4. Jandrot-Perrus M., Busfield S., Lagrue A.H., Xiong X., Debili N., Chickering T., et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 2000 Sep 1, 96(5):1798-1807.
5. Rosendaal F.R., Helmerhorst F.M., Vandenbroucke J.P. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002 Feb 1, 22(2):201-210.
6. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 Aug 19, 280(7):605-613.
7. Dorn J.M., Hovey K., Williams B.A., Freudenheim J.L., Russell M., Nochajski T.H., et al. Alcohol drinking pattern and non-fatal myocardial infarction in women. Addiction 2007 May, 102(5):730-739.
8. Trevisan M., Dorn J., Falkner K., Russell M., Ram M., Muti P., et al. Drinking pattern and risk of non-fatal myocardial infarction: a population-based case-control study. Addiction 2004 Mar, 99(3):313-322.
9. Beaglehole R., Stewart A.W., Butler M. Comparability of old and new World Health Organization criteria for definite myocardial infarction. Int J Epidemiol 1987 Sep, 16(3):373-376.
10. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003 May 21, 289(19):2560-2572.
11. Allain C.C., Poon L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974 Apr, 20(4):470-475.
12. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999 Feb, 14(5-6):143-149.
13. Sinnwell J.P.S.D., Yu Z. The haplo.stats Package 2003, Mayo Foundation for Medical Education and Research. 1.3.8 ed.
14. Bray P.F., Howard T.D., Vittinghoff E., Sane D.C., Herrington D.M. Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy. Blood 2007 Mar 1, 109(5):1862-1869.
15. Croft S.A., Samani N.J., Teare M.D., Hampton K.K., Steeds R.P., Channer K.S., et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001 Sep 25, 104(13):1459-1463.
16. Ollikainen E., Mikkelsson J., Perola M., Penttila A., Karhunen P.J. Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men. Atherosclerosis 2004 Sep, 176(1):95-99.
17. Takagi S., Iwai N., Baba S., Mannami T., Ono K., Tanaka C., et al. A GPVI polymorphism is a risk factor for myocardial infarction in Japanese. Atherosclerosis 2002 Dec, 165(2):397-398.
18. The International HapMap Project. Nature 2003 Dec 18, 426(6968):789-796.
19. Joutsi-Korhonen L., Smethurst P.A., Rankin A., Gray E., Ij M., Onley C.M., et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003 Jun 1, 101(11):4372-4379.